Simon A. Smith

3.0k total citations
64 papers, 2.0k citations indexed

About

Simon A. Smith is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Simon A. Smith has authored 64 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 33 papers in Oncology and 16 papers in Genetics. Recurrent topics in Simon A. Smith's work include PARP inhibition in cancer therapy (18 papers), DNA Repair Mechanisms (16 papers) and BRCA gene mutations in cancer (12 papers). Simon A. Smith is often cited by papers focused on PARP inhibition in cancer therapy (18 papers), DNA Repair Mechanisms (16 papers) and BRCA gene mutations in cancer (12 papers). Simon A. Smith collaborates with scholars based in United Kingdom, United States and South Korea. Simon A. Smith's co-authors include Douglas F. Easton, B. A. J. Ponder, D. Gareth Evans, David Shepherd, Emma Dean, Deborah Ford, B. A. J. Ponder, S A Narod, JudyE. Garber and Rósa B. Barkardóttir and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Simon A. Smith

61 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon A. Smith United Kingdom 23 1.1k 794 649 296 295 64 2.0k
Marco J. Koudijs Netherlands 23 1.4k 1.3× 401 0.5× 491 0.8× 781 2.6× 236 0.8× 45 2.3k
Thomas G. Boyer United States 32 2.2k 2.1× 588 0.7× 434 0.7× 302 1.0× 150 0.5× 58 3.3k
Norbert Arnold Germany 35 2.0k 1.9× 1.4k 1.8× 652 1.0× 905 3.1× 399 1.4× 125 3.6k
J.M.N. Hoovers Netherlands 24 1.3k 1.2× 1.0k 1.3× 183 0.3× 136 0.5× 161 0.5× 59 2.1k
Lucio H. Castilla United States 23 2.2k 2.1× 651 0.8× 317 0.5× 311 1.1× 162 0.5× 46 3.2k
Micah D. Gearhart United States 24 1.4k 1.3× 495 0.6× 185 0.3× 160 0.5× 124 0.4× 48 1.9k
Jungmin Choi United States 21 767 0.7× 403 0.5× 557 0.9× 253 0.9× 183 0.6× 76 1.9k
Hiroaki Nitta United States 25 633 0.6× 619 0.8× 749 1.2× 271 0.9× 152 0.5× 51 2.1k
Georg Beckmann Germany 16 1.5k 1.4× 234 0.3× 549 0.8× 583 2.0× 290 1.0× 36 2.3k
Pradeep S. Tanwar Australia 27 880 0.8× 311 0.4× 339 0.5× 222 0.8× 70 0.2× 63 1.9k

Countries citing papers authored by Simon A. Smith

Since Specialization
Citations

This map shows the geographic impact of Simon A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon A. Smith more than expected).

Fields of papers citing papers by Simon A. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon A. Smith. The network helps show where Simon A. Smith may publish in the future.

Co-authorship network of co-authors of Simon A. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Simon A. Smith. A scholar is included among the top collaborators of Simon A. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon A. Smith. Simon A. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, David C., Elisabeth I. Heath, Frank C. Cackowski, et al.. (2025). Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP). JCO Precision Oncology. 9(9). e2500457–e2500457.
2.
Simpkins, Fiona, Dimitrios Nasioudis, Stephanie L. Wethington, et al.. (2024). Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-sensitive epithelial ovarian cancer (cohort A).. Journal of Clinical Oncology. 42(16_suppl). 5510–5510. 7 indexed citations
3.
Park, Sehhoon, Yu Jung Kim, Young Joo Min, et al.. (2023). Biomarker‐driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer. Cancer. 130(4). 541–552. 15 indexed citations
4.
Wethington, Stephanie L., Payal D. Shah, Lainie P. Martin, et al.. (2023). C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer. Clinical Cancer Research. 29(15). 2800–2807. 40 indexed citations
5.
Kim, Seung Tae, Simon A. Smith, Peter G. Mortimer, et al.. (2021). Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer. Clinical Cancer Research. 27(17). 4700–4709. 61 indexed citations
6.
Yap, Timothy A., Matthew Krebs, Sophie Postel‐Vinay, et al.. (2021). Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study. Clinical Cancer Research. 27(19). 5213–5224. 71 indexed citations
7.
8.
Kwon, Minsuk, Minae An, S.T. Kim, et al.. (2021). Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy. Annals of Oncology. 33(2). 193–203. 81 indexed citations
9.
Laws, Thomas R., et al.. (2005). The nematodePanagrellus redivivusis susceptible to killing by human pathogens at 37 °C. FEMS Microbiology Letters. 250(1). 77–83. 13 indexed citations
10.
Pieretti, Maura, Nada H. Khattar, & Simon A. Smith. (2001). Common polymorphisms and somatic mutations in human base excision repair genes in ovarian and endometrial cancers. PubMed. 432(3-4). 53–59. 43 indexed citations
11.
Smith, Simon A., et al.. (2001). Abdominal actinomycosis following a forgotten intrauterine contraceptive device. Hospital Medicine. 62(6). 366–367. 3 indexed citations
12.
Richards, William E., et al.. (1999). BRCA1-Related and Sporadic Ovarian Cancer in the Same Family: Implications for Genetic Testing. Gynecologic Oncology. 75(3). 468–472. 4 indexed citations
13.
Albertsen, Hans, Simon A. Smith, Roberta Melis, et al.. (1996). Sequence, Genomic Structure, and Chromosomal Assignment of Human DOC-2. Genomics. 33(2). 207–213. 38 indexed citations
14.
Smith, Simon A., Jeff Stevens, Sylvie Mazoyer, et al.. (1996). Isolation of a Gene (DLG3) Encoding a Second Member of the Discs-Large Family on Chromosome 17q12–q21. Genomics. 31(2). 145–150. 31 indexed citations
15.
Miller, Robert G., Wilson W. Bryan, T. L. Munsat, et al.. (1996). Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis. Neurology. 47(5). 1329–1331. 75 indexed citations
16.
Smith, Simon A., et al.. (1995). Isolation and Mapping of a Gene Encoding a Novel Human ADP-Ribosylation Factor on Chromosome 17q12-q21. Genomics. 28(1). 113–115. 17 indexed citations
17.
Gallion, Holly H. & Simon A. Smith. (1994). Hereditary ovarian carcinoma. Seminars in Surgical Oncology. 10(4). 249–254. 9 indexed citations
18.
Wooster, Richard, Jonathan Mangion, Rosalind A. Eeles, et al.. (1992). A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genetics. 2(2). 132–134. 165 indexed citations
19.
Smith, Simon A., Douglas F. Easton, D. Gareth Evans, & B. A. J. Ponder. (1992). Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome. Nature Genetics. 2(2). 128–131. 327 indexed citations
20.
Smith, Simon A., Parveen Kumar, I.R. Johnston, & John Rosamond. (1992). SCM4, a gene that suppresses mutant cdc4 function in budding yeast. Molecular and General Genetics MGG. 235(2-3). 285–291. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco J. Koudijs Breakdown of academic impact, for papers by Thomas G. Boyer Breakdown of academic impact, for papers by Norbert Arnold Breakdown of academic impact, for papers by J.M.N. Hoovers Breakdown of academic impact, for papers by Lucio H. Castilla Breakdown of academic impact, for papers by Micah D. Gearhart Breakdown of academic impact, for papers by Jungmin Choi Breakdown of academic impact, for papers by Hiroaki Nitta Breakdown of academic impact, for papers by Georg Beckmann Breakdown of academic impact, for papers by Pradeep S. Tanwar
Rankless by CCL
2026